Cell Meter™ Live Cell Caspase 3/7 and Phosphatidylserine Detection Kit *Triple Fluorescence Colors*
Example protocol
AT A GLANCE
- Prepare cells with test compounds at a density of 2 × 106 cells/mL
- Add TF3-DEVD-FMK at 1:150 ratio and/or Annexin V-iFluor 488™ into cell solution at 1:100 ratio
- Incubate the cells in a 37°C, 5% CO2 incubator for 1 hour.
- Pellet the cells, wash and resuspend the cells with buffer or growth medium
- Monitor fluorescence intensity (bottom read mode) at Ex/Em = 490/525 nm (Cutoff = 515 nm) and/or 550/595 nm (Cutoff = 570 nm), fluorescence microscope with FITC and TRITC filters, or flow cytometer with FL1 and FL2 channels for Annexin V-iFluor 488™ and TF3-DEVD-FMK respectively
Thaw all the components at room temperature before starting the experiment.
CELL PREPARATION
For guidelines on cell sample preparation, please visit https://www.aatbio.com/resources/guides/cell-sample-preparation.html
PREPARATION OF STOCK SOLUTIONS
Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles
Add 75 µL of DMSO into the vial of TF3-DEVD-FMK (Component A) to make 150X TF3-DEVD-FMK stock solution.
SAMPLE EXPERIMENTAL PROTOCOL
- Culture cells to a density optimal for apoptosis induction according to your specific induction protocol, but not to exceed 2 x 106 cells/ mL (or not to exceed 3 x 105 cells/100 µL/well in a 96-well black clear-bottom plate). At the same time, culture a non-induced negative control cell population at the same density as the induced population for every labeling condition. Here are a few examples for inducing apoptosis in suspension culture:
- Treating Jurkat cells with 2 µg/ml camptothecin for 3 hours.
- Treating Jurkat cells with 1 µM staurosporine for 3 hours.
- Treating HL-60 cells with 4 µg/ml camptothecin for 4 hours.
- Treating HL-60 cells with 1 µM staurosporine for 4 hours.
Note Each cell line should be evaluated on an individual basis to determine the optimal cell density for apoptosis induction.
- Add 150X TF3-DEVD-FMK stock solution at a 1:150 ratio and/or Annexin V-iFluor 488™ (Component B) at 1:100 ratio into each well.
- Incubate the cells in a 37°C, 5% CO2 incubator for 1 hour.
Note The cells can be concentrated up to ~ 5 X 106 cells/mL for TF3-DEVD-FMK labeling. For adherent cells, gently lift the cells with 0.5 mM EDTA to keep the cells intact, and wash the cells once with serum-containing media prior to incubation with TF3 -DEVD-FMK. The appropriate incubation time depends on the individual cell type and cell concentration used. Optimize the incubation time for each experiment. Annexin V flow cytometric analysis on adherent cells is not routinely tested since specific membrane damage may occur during cell detachment or harvesting. However, methods for utilizing Annexin V for flow cytometry on adherent cell types have been previously reported by Casiola-Rosen et al. and van Engelend et al. - If desired, label the cells with a DNA stain (such as Hoechst for whole population of the cell nucleus stain, or propidium iodide for dead cells if the cells label with Annexin V-iFluor 488™ only).
- Spin down the cells at ~200g for 2 minutes and wash cells with 1 mL (or 200 µL/well if using 96-well plate) Washing Buffer (Component E) twice. Resuspend the cells in desired amount of washing buffer.
Note TF3-DEVD-FMK and Annexin V-iFluor 488™ are fluorescent, thus it is important to wash out any unbound reagent to eliminate the background. For detached cells, the concentration of cells should be adjusted to 2-5 X 105 cells/100 µL aliquot per microtiter plate well. - Monitor the fluorescence intensity by fluorescence microscope, flow cytometer, or fluorescence microplate reader at Ex/Em = 550/595 nm for TF3-DEVD-FMK, 490/525 for Annexin V-iFluor 488™, 350/461 nm for Hoechst stain, and 535/635 for propidium iodide.
For flow cytometry: Monitor the fluorescence intensity using FL1 channel for Annexin V-iFluor 488™, FL2 channel for TF3-DEVD-FMK. Gate on the cells of interest, excluding debris.
For fluorescence microscope: Place 100 µL of the cell suspensions into each of wells of a 96-well black microtiter plate. Observe cells under a fluorescence microscope using TRITC channel for TF3-DEVD-FMK, and/or FITC channel for Annexin V-iFluor 488™ (TRITC channel for propidium iodide staining, DAPI channel for Hoechst staining).
For fluorescence microplate reader: Place 100 µL of the cell suspensions into each of wells of a 96-well black microtiter plate. Monitor the fluorescence intensity (bottom read mode) with a fluorescence microplate reader at Ex/Em = 490/525 nm (Cutoff = 515 nm) for Annexin V-iFluor 488™, and/or 550/595 nm (Cutoff = 570 nn) for TF3-DEVD-FMK.
Note If it is necessary to equilibrate the cell concentrations, adjust the suspension volume for the induced cells to approximate the cell density of the non-induced population. This adjustment step is optional if your cell treatment does not result in a dramatic loss in stimulated cell population numbers.
Citations
Authors: Shen, Xiaochang and Wang, Jiandong and Deng, Boer and Chen, Shuning and John, Catherine and Zhao, Ziyi and Sinha, Nikita and Haag, Jennifer and Sun, Wenchuan and Kong, Weimin and others,
Journal: Gynecologic Oncology (2024): 93--102
Authors: Sariboyaci, Ayla Eker and Uysal, Onur and Soykan, Merve Nur and Gunes, Sibel
Journal: (2022)
Authors: Gunes, Sibel and Soykan, Merve Nur and Sariboyaci, Ayla Eker and Uysal, Onur and Sevimli, Tugba Semerci
Journal: Medical Oncology (2021): 1--10
Authors: Tavares, Raquel and Pathak, Sushil Kumar
Journal: Frontiers in Cellular and Infection Microbiology (2017): 58
Authors: Nanashima, Naoki and Horie, Kayo and Chiba, Mitsuru and Nakano, Manabu and Maeda, Hayato and Nakamura, Toshiya
Journal: Molecular Medicine Reports (2017): 6134--6141
References
Authors: Heinrich A, Balszuweit F, Thiermann H, Kehe K.
Journal: Toxicol Lett (2009): 260
Authors: Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H.
Journal: Toxicol Lett (2009): 156
Authors: Domart MC, Esposti DD, Sebagh M, Olaya N, Harper F, Pierron G, Franc B, Tanabe KK, Debuire B, Azoulay D, Brenner C, Lemoine A.
Journal: J Hepatol (2009): 881
Authors: Kreeger PK, M and hana R, Alford SK, Haigis KM, Lauffenburger DA.
Journal: Cancer Res (2009): 8191
Authors: Elders RC, Baines SJ, Catchpole B.
Journal: Vet Immunol Immunopathol (2009): 11